IT 2 - Imunisasi Remaja - YLI

26
ADOLESCENT IMMUNIZATION

description

IT 2 - Imunisasi Remaja - YLI

Transcript of IT 2 - Imunisasi Remaja - YLI

ADOLESCENT IMMUNIZATION

Introduction

¨  Children ¤  UU No. 23 tahun 2002: 0 – 18 tahun

¨  Adolescent ¤  WHO (~ Depkes): 10 – 19 tahun

¨  Annual wellness visits are generally recommended for adolescents aged 11 to 17 years, with recommended adolescent vaccines administered at age 11 or 12 years

¨  National adolescent immunization ¤  Has not been implemented properly ¤  Less attention from both parents and government

Why are these vaccines recommended?

¨  Risk of serious diseases ¤ Decreased immune response

n  Pertusis

¤ Childhood immunization coverage not optimal n  Vaccines preventable diseases increase in adolescent

¤  Specific disesases risk in adulthood n  Cervical Ca, Hepatitis B

¨  Good vaccines ¤ Highly effective ¤  Excellent safety profile VACCINES DISEASES

Objective

¨  Routine immunization ¨  Booster ¨  Catch-up immunization ¨  Herd immunity ¨  Reduce the risk of diseases in adulthood

Immunization according to age

¨  10 – 13 yrs = early adolescent ¤ Routine immunization

¨  14 – 16 yrs = middle adolescent ¤ Catch-up immunization

¨  17 – 19 yrs = late adolescent

Routine vaccines in early adolescent

¨  Influenza (1 dose per year) ¨  Human papilomavirus (3 primary doses) ¨  Conjugated meningococcal vaccine (1 primary dose) ¨  Tdap (1 booster dose) / Td

Catch-up immunization in adolescent

¨  For adolescent who did not receive complete immunization ¤ Hepatitis B ¤ Polio ¤ MMR ¤ Varicella ¤ Certain vaccines for adolescents at high risk of

diseases: n Hepatitis A n Pneumococcal polysaccharide

Catch-up immunization – late adolescent

¨  For all vaccines: completed!

Why are these vaccines recommended?

¨  Risk of serious diseases ¤ Decreased immune response

n  Pertusis

¤ Childhood immunization coverage not optimal n  Vaccines preventable diseases increase in adolescent

¤  Specific disesases risk in adulthood n  Cervical Ca, Hepatitis B

¨  Good vaccines ¤ Highly effective ¤  Excellent safety profile VACCINES DISEASES